15 results
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall
20-F
2021 FY
IINN
Inspira Technologies Oxy B.H.N. Ltd
31 Mar 22
Annual report (foreign)
4:48pm
penalties, and might require us to recall or withdraw a product from the market;
our products may cause or contribute to adverse medical events … harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall
POS AM
2jsqjdjkmw0 vhds
27 Oct 21
Prospectus update (post-effective amendment)
9:17am
424B4
dqac40pf
15 Jul 21
Prospectus supplement with pricing info
4:06pm
F-1/A
jr1z4n hcwsc1
1 Jul 21
Registration statement (foreign) (amended)
11:58am
F-1/A
7mupchz
28 Jun 21
Registration statement (foreign) (amended)
11:41am
F-1/A
w8ptnfbcce
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
ume ox5o8fp
29 Mar 21
Registration statement (foreign) (amended)
5:19pm
F-1/A
dqlqpfa5yair0mn6jr
22 Mar 21
Registration statement (foreign) (amended)
11:24am
F-1
9fa8fvp hfhbmr
5 Mar 21
Registration statement (foreign)
3:03pm
DRS/A
u679bxa
17 Feb 21
Draft registration statement (amended)
12:00am
DRS
shc 8vo9ev8yly
29 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next